EXP-561 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "EXP-561" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
1,182nd place
725th place
11th place
8th place
6,663rd place
5,792nd place

aspetjournals.org (Global: 6,663rd place; English: 5,792nd place)

jpet.aspetjournals.org

doi.org (Global: 2nd place; English: 2nd place)

  • Fuller RW, Snoddy HD, Perry KW (November 1976). "Inhibition of amine uptake by 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561) in rats". biochemical Pharmacology. 25 (21): 2409–2410. doi:10.1016/0006-2952(76)90039-3. PMID 999731.
  • BK K (December 1976). "Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain". The Journal of Pharmacology and Experimental Therapeutics. 199 (3): 649–661. doi:10.1016/S0022-3565(25)30726-3. PMID 994022.
  • Wong DT, Molloy BB, Bymaster FP (January 1977). "Blockade of monoamine uptake by 1-amino-4-phenylbicyclo(2,2,2)octane (EXP 561) in rat brain and heart". Neuropharmacology. 16 (1): 11–15. doi:10.1016/0028-3908(77)90040-5. PMID 834358. S2CID 44365500.
  • Maj J, Skuza G, Sowińska H, Nowak G (1987). "Pharmacological properties of EXP 561, a potential antidepressant drug". Journal of Neural Transmission. 70 (1–2): 81–97. doi:10.1007/BF01252511. PMID 2822850. S2CID 23469131.
  • Davis JM (1970). "Theories of biological etiology of affective disorders". In Pfeiffer CC, Smythies JR (eds.). International Review of Neurobiology. Vol. 12. pp. 145–175. doi:10.1016/s0074-7742(08)60060-4. ISBN 978-0-12-366812-7. PMID 4918142.
  • Ross SB, Kelder D (May 1979). "Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum". Acta Pharmacologica et Toxicologica. 44 (5): 329–335. doi:10.1111/j.1600-0773.1979.tb02339.x. PMID 474143.

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

  • Fuller RW, Snoddy HD, Perry KW (November 1976). "Inhibition of amine uptake by 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561) in rats". biochemical Pharmacology. 25 (21): 2409–2410. doi:10.1016/0006-2952(76)90039-3. PMID 999731.
  • BK K (December 1976). "Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain". The Journal of Pharmacology and Experimental Therapeutics. 199 (3): 649–661. doi:10.1016/S0022-3565(25)30726-3. PMID 994022.
  • Wong DT, Molloy BB, Bymaster FP (January 1977). "Blockade of monoamine uptake by 1-amino-4-phenylbicyclo(2,2,2)octane (EXP 561) in rat brain and heart". Neuropharmacology. 16 (1): 11–15. doi:10.1016/0028-3908(77)90040-5. PMID 834358. S2CID 44365500.
  • Maj J, Skuza G, Sowińska H, Nowak G (1987). "Pharmacological properties of EXP 561, a potential antidepressant drug". Journal of Neural Transmission. 70 (1–2): 81–97. doi:10.1007/BF01252511. PMID 2822850. S2CID 23469131.
  • Davis JM (1970). "Theories of biological etiology of affective disorders". In Pfeiffer CC, Smythies JR (eds.). International Review of Neurobiology. Vol. 12. pp. 145–175. doi:10.1016/s0074-7742(08)60060-4. ISBN 978-0-12-366812-7. PMID 4918142.
  • Lehmann HE, Ban TA, Debow SL (June 1967). "A clinical-pharmacological study with EXP 561". Current Therapeutic Research, Clinical and Experimental. 9 (6): 306–308. PMID 4963065.
  • Gershon S, Hekimian LJ, Floyd A (February 1968). "Non-correlation of preclinical-clinical evaluation of a prosposed anti-depressant 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561)". Arzneimittel-Forschung. 18 (2): 243–245. PMID 5695389.
  • Ross SB, Kelder D (May 1979). "Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum". Acta Pharmacologica et Toxicologica. 44 (5): 329–335. doi:10.1111/j.1600-0773.1979.tb02339.x. PMID 474143.
  • Carenini G, Carissimi M, D'Ambrosio R, Grumelli E, Milla E, Ravenna F (1973). "[Phenylcyclohexylamine and derivatives. IV. Salts of trans-4-phenylcyclohexylamine with -substituted 4-diphenyl- and 4-cyclohexylphenyl acetic acids and their pharmacological activity]". Il Farmaco; Edizione Scientifica. 28 (4): 265–277. PMID 4698884.

patents.google.com (Global: 1,182nd place; English: 725th place)

  • US 3362878, Snyder JA, "Pharmaceutical compositions and methods utilizing substituted bicyclo[2.2.2]-octanes", issued 9 January 1968, assigned to EIDP Inc. 
  • US 3308160, Snyder JA, "4-Phenylbicyclo[2.2.2]octane-1-amines and salts thereof", issued 7 March 1967, assigned to EIDP Inc. 

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org